| 1 | New | 2.08% | |
| 2 | Cancer | 2.08% | |
| 3 | Dental | 1.04% | |
| 4 | Perfect | 1.04% | |
| 5 | Clues | 1.04% | |
| 6 | Control | 1.04% | |
| 7 | Testing | 1.04% | |
| 8 | Animal | 1.04% | |
| 9 | Immune | 1.04% | |
| 10 | Analyzed | 1.04% | |
| 11 | Subarachnoid | 1.04% | |
| 12 | Sperm | 1.04% | |
| 13 | Pre | 1.04% | |
| 14 | Deaths | 1.04% | |
| 15 | Uncovers | 1.04% | |
| 16 | Burden | 1.04% | |
| 17 | Islets | 1.04% | |
| 18 | Study | 1.04% | |
| 19 | PJs | 1.04% | |
| 20 | Infection | 1.04% | |
| 21 | Couples | 1.04% | |
| 22 | Oral | 1.04% | |
| 23 | Chadstone | 1.04% | |
| 24 | CSL | 1.04% | |
| 25 | Hijack | 1.04% | |
| 26 | Vascularized | 1.04% | |
| 27 | Cell-Derived | 1.04% | |
| 28 | Therapy | 1.04% | |
| 29 | Molecular | 1.04% | |
| 30 | Pandemic | 1.04% | |
| 31 | Excellence | 1.04% | |
| 32 | Machine | 1.04% | |
| 33 | Vitamin | 1.04% | |
| 34 | Colorectal | 1.04% | |
| 35 | Learning | 1.04% | |
| 36 | ALS | 1.04% | |
| 37 | Unveils | 1.04% | |
| 38 | Dana-Farber | 1.04% | |
| 39 | Europe | 1.04% | |
| 40 | Nephropathy | 1.04% | |
| 41 | CU | 1.04% | |
| 42 | Excess | 1.04% | |
| 43 | Emerging | 1.04% | |
| 44 | Skin | 1.04% | |
| 45 | Finds | 1.04% | |
| 46 | Anschutz | 1.04% | |
| 47 | Hunter | 1.04% | |
| 48 | Interventions | 1.04% | |
| 49 | Nice | 1.04% | |
| 50 | Filspari®? | 1.04% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||
CSL Vifor Announces England's Nice Recommends Filspari®? as A Treatment Option for IgA Nephropathy
marketscreener.com
2025-05-23 18:20:26